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Abstract
Background: The selection of genes that discriminate disease classes from microarray data is widely used for the
identification of diagnostic biomarkers. Although various gene selection methods are currently available and some
of them have shown excellent performance, no single method can retain the best performance for all types of
microarray datasets. It is desirable to use a comparative approach to find the best gene selection result after
rigorous test of different methodological strategies for a given microarray dataset.
Results: FiGS is a web-based workbench that automatically compares various gene selection procedures and
provides the optimal gene selection result for an input microarray dataset. FiGS builds up diverse gene selection
procedures by aligning different feature selection techniques and classifiers. In addition to the highly reputed
techniques, FiGS diversifies the gene selection procedures by incorporating gene clustering options in the feature
selection step and different data pre-processing options in classifier training step. All candidate gene selection
procedures are evaluated by the .632+ bootstrap errors and listed with their classification accuracies and selected
gene sets. FiGS runs on parallelized computing nodes that capacitate heavy computations. FiGS is freely accessible
at http://gexp.kaist.ac.kr/figs.
Conclusion: FiGS is an web-based application that automates an extensive search for the optimized gene selection
analysis for a microarray dataset in a parallel computing environment. FiGS will provide both an efficient and
comprehensive means of acquiring optimal gene sets that discriminate disease states from microarray datasets.
Background
Gene selection methods for microarray data analysis are
important to identify the significant genes that distin-
guish disease classes and to use these selected genes as
diagnostic markers in clinical decisions. Due to the sig-
nificance of this matter, many gene selection methods
have been introduced. Each method demonstrated a
proper level of quality to predict disease states in its
own test datasets, but the performance level was only
partially validated in the sense that a limited number of
sample datasets, gene selection algorithms, and the para-
meters in the test were used. It is not only difficult to
choose the best performing gene selection method
among many methods for a newly introduced dataset, it
is also doubtful if such methods exist that can always
guarantee the performance with all types of microarray
datasets. A desirable approach would be to find and use
a gene selection procedure that is optimized for each
microarray dataset in question through a rigorous per-
formance test of representative types of methods while
varying the parameters in the methods. To complete
these complex works conveniently and efficiently, the
tool should automate the comprehensive tests and facili-
tate high-performance computing.
There have been several tools that support a compara-
tive analysis of different gene selection methods. Prophet
enables a comparison of the performance of different
feature selection methods and classifiers with leave-one-
out cross-validation (LOOCV) errors [1]. The proce-
dures are automated to test the multiple classifiers but
the user should select each feature selection method.
Gene Expression Model Selector (GEMS) provides an
automatic selection of several feature selection methods
and different types of multi-category support vector
machine (MC-SVM) algorithms [2]. The authors con-
cluded that MC-SVM was the most effective classifier
after a test of several different types of classifiers,
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method, K-nearest neighbors and neural networks.
M@CBETH [3] is a tool designed to compare only clas-
sification algorithms. The aforementioned tools are use-
ful but each has room for improvement in terms of
automation, the diversity of method comparisons, or the
information content in the output report.
The present study introduces FiGS, a new web-based
gene selection workbench. FiGS automates the genera-
tion and evaluation of various gene selection procedures
in a parallel computation environment. In addition to
the well established feature selection methods and clas-
sification algorithms, FiGS uniquely incorporates several
methodological options which can improve performance
in certain types of datasets. Those involve the specified
selection of up- or down-regulated genes in the feature
selection step, feature discretization, and new feature
vector formation with the addition of the expression
vectors of the selected genes in classifier training step. A
test using six cancer microarray datasets showed that
different types of gene selection procedures should be
applied to obtain the optimal gene sets for each dataset.
Implementation
FiGS generates gene selection procedures having two
separate steps: feature selection and classifier training
(Figure 1). The feature selection step is used for the
prioritization of differentially expressed genes. The dis-
tributional assumption for microarray data can change
for each dataset based on the dataset size, presence of
experimental artifacts, underlying gene expression setup
and other factors [4]. One of our goals is to find proper
statistical measures that match these unknown types of
microarray data distributions automatically. To facilitate
this process, three proven test statistics were selected
from among a wide range of parametric and non-para-
metric or model-free methods. The t-test and the Wil-
coxon rank sum test were included as a representative
parametric and non-parametric analysis, respectively. In
addition, an information gain method using an entropy-
based discretization measure [5] was included as another
type of non-parametric method. Using these methods,
FiGS can evaluate the significance of genes with diverse
input data features: the original numeric values, the
rank-transformed values and discretized values. In addi-
tion, we designed a new option to specify up- or down-
regulated genes for input. The genes are assigned to up-
or down-regulated genes based on their differential
expression in two classes. In some cases, the selection of
genes in those separate groups can enhance the classifi-
cation power (See Table 1 to find the examples in our
test). During the classifier training step, the support vec-
tor machine (SVM) [6] and the random forest [7] meth-
ods were incorporated. These are the state-of-the-art
classification algorithms that showed excellent perfor-
mance in recent comparative analyses [8,9]. The features
used for classifier training can be diversified in two
types: the original values and the discretized values. Pre-
vious studies showed that feature discretization can con-
siderably improve classification performance [10,11]. In
addition, we developed a new form of feature vector for
classifier training. It forms a new feature vector by add-
ing the gene expression features of selected genes
(Figure 2). As shown in Figure 2, it can generate an
improved feature by amplifying a similar expression pat-
tern or offsetting the outliers. The performance of clas-
sifier is evaluated by the .632+ bootstrap method [12].
All algorithms in the introduced gene selection proce-
dure are implemented in R [13]. The e1071 [14] and ran-
domForest [15] R-package were used to implement the
SVM and the random forest, respectively. The computa-
tions are parallelized using the Parallel Virtual Machine
(PVM) via the rpvm [16] and snow [17] in the R-packages
on a cluster of 9 nodes, each with dual quad-core Intel
Xeon 2.46 GHz CPUs and 24 Gb RAM.
In the web-based user interface, FiGS takes a two-class
microarray dataset as input in a tab-delimited text file.
Users are allowed to run the default setup suggested by
FiGS or to design their own comparative study by select-
ing from among the methods and techniques described
above. Users can specify several desired numbers of
genes to be selected. The output reports the performance
of each gene selection procedure with the selected genes.
The output is available through the web site or can be
automatically emailed upon a user’s request.
Results
Several analyses were conducted to demonstrate the
necessity and usefulness of the comprehensive approach
of FiGS. We tested the performance of all the possible
gene selection procedures that can be generated by FiGS
to six binary (two-class) microarray datasets. The micro-
array datasets were chosen from the literature because
they have been extensively analyzed in previous publica-
tions. The six microarray datasets were as follows:
leukemia (33 samples with 3051 genes) [18], colon (64
samples with 2000 genes) [19], prostate (102 samples
with 6033 genes) [20], adenocarcinoma (76 samples with
9868 genes) [21], breast (77 samples with 4869 genes)
[22], and diffuse B-cell lymphoma (DLBCL) (77 samples
with 5469 genes) [23]. Figure 3 shows the range of .632
+ bootstrap errors in the classification models generated
by all the gene selection procedures for each microarray
dataset. Even in the same dataset, the errors differ
greatly depending on which gene selection procedure is
used. The deviation between the best and worst .632+
bootstrap error for a dataset is in the range of 0.09 (ade-
nocarcinoma) to 0.15 (leukemia). This range implies that
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cation model if an inappropriate gene selection proce-
dure is used without caution. In addition, the best
performing gene selection procedures for each datasets
are different. We examined the best performing meth-
ods which produce the smallest .632+ bootstrap errors
with a minimum number of genes for each dataset. The
best optimized methods for each dataset are listed in
Table 1 with their .632+ bootstrap errors and the num-
ber of selected genes. For the feature selection step, we
found in all six cases that the model-free or non-para-
metric methods are preferable to the parametric t-test.
According to the literature, non-parametric methods are
more applicable in the analysis of microarray data,
where the sample size is often small and an underlying
distribution can be hardly assumed [4]. Nevertheless,
some microarray datasets can be appropriate for the
parametric t-test, especially studies involving large num-
bers of samples. Within two non-parametric methods,
we can notice that there is no dominant appearance of a
Figure 1 Various gene selection procedures in FiGS. As many as 60 different gene selection procedures can be developed by combining the
feature selection methods, classification algorithms and various optional techniques. The feature vector addition technique is applied only to
cases where the specified selection of up-regulated or down-regulated genes is used in the feature selection step. The range for the number of
genes can be also set by users, though it is not shown here.
Figure 2 The feature vector addition technique. The symbol Cij is the jth sample in the ith class. The darker gray represents the higher
expression values.
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the six microarray datasets.
Dataset Feature selection
method
k Gene expression
pattern
Feature
discretization
Feature vector
addition
Classifier Error
Leukemia Wilcoxon rank sum test 10 Down-regulated Not apply Not apply SVM 0.02
Leukemia Wilcoxon rank sum test 10 Down-regulated Not apply Not apply RF 0.02
Leukemia Wilcoxon rank sum test 10 Down-regulated Not apply Apply SVM 0.02
Leukemia Wilcoxon rank sum test 10 Down-regulated Not apply Apply RF 0.02
Leukemia Wilcoxon rank sum test 10 Down-regulated Apply Not apply SVM 0.02
Leukemia Information gain method 10 Down-regulated Not apply Not apply SVM 0.02
Leukemia Information gain method 10 Down-regulated Not apply Not apply RF 0.02
Leukemia Information gain method 10 Down-regulated Not apply Apply SVM 0.02
Leukemia Information gain method 10 Down-regulated Not apply Apply RF 0.02
Leukemia Information gain method 10 Down-regulated Apply Not apply SVM 0.02
Leukemia Information gain method 10 Down-regulated Apply Not apply RF 0.02
Colon Information gain method 30 Up-regulated Not apply Not apply RF 0.11
Prostate Information gain method 25 Total Not apply Not apply RF 0.05
Adenocarcinoma Wilcoxon rank sum test 10 Up-regulated Not apply Not apply RF 0.10
Breast Wilcoxon rank sum test 15 Down-regulated Not apply Apply SVM 0.31
Breast Information gain method 15 Down-regulated Not apply Apply SVM 0.31
DLBCL Wilcoxon rank sum test 20 Total Not apply Not apply RF 0.08
k is the number of selected genes; and error is the .632+ bootstrap error achieved by the best performing gene selection procedure tested on 100 bootstrap
samples. In the case of the leukemia and breast datasets, the multiple gene selection procedures are the best.
Figure 3 Box plots of the .632+ bootstrap errors obtained by different gene selection procedures for each of the six cancer
microarray datasets.
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information gain method can be used for leukemia and
breast datasets. However, the best feature selection
method for the adenocarcinoma and DLBCL datasets is
the Wilcoxon rank sum test, and the best method for
the colon and prostate datasets is the information gain
method. For the classifiers, the SVM and the random
forest are both competitive, though as with the feature
selection methods the applicability of each method dif-
fers for each dataset. The random forest was chosen for
the colon, prostate, adenocarcinoma, and DLBCL dat-
sets; the SVM was selected for the breast dataset. There
is no correlation between the types of feature selection
method and classifiers among the best selected proce-
dures. Note also that our newly developed methodologi-
cal designs in FiGS are frequently selected as part of the
best gene selection procedures for those datasets. Those
are the strategy to select the genes in a separate group
having up- or down-regulated pattern and the feature
vector addition technique. All the results underscore the
need for a comprehensive comparison of the many
applicable procedures.
Using the same six microarray datasets, we compared
the classification performance of the best gene selection
procedures found in FiGS with those of typical gene selec-
tion approaches. Six gene selection procedures were fabri-
cated by combining three feature selection methods
(namely, the t-test, the Wilcoxon rank sum test, and the
information gain method) with two classification algo-
rithms (namely, the SVM and random forest). The num-
ber of genes to select was set to 200 on the assumption
that 200 is a sufficiently large number for those six meth-
ods to give their best performance. While substantially
optimizing the number of genes, FiGS could find better, or
at least comparable, level of classification accuracy than
that achieved by the six methods (Figure 4) with much
fewer genes. The number of genes that satisfies the level
of accuracy for FiGS as shown in Figure 4 is 50 for leuke-
mia, 30 for colon, 25 for prostate, 10 for adenocarcinoma,
15 for breast, and 70 for DLBCL. We also tried to compare
the performance of FiGS with recently published methods.
However, it is hard to fairly and comprehensively evaluate
the performance of different gene selection methods due
to the different setups of the experimental design, datasets,
and the performance definitions [2]. Of the various meth-
ods, we found varSelRF, a gene selection method based on
random forest backward feature elimination [15], as an
appropriate method that can be readily compared with
FiGS. The classification performances of varSelRF for all
datasets that FiGS has tested except the DLBCL dataset
are available in [8]. For the DLBCL dataset, we obtained
the results by using the varSelRF tools provided by the
R-package. Figure 4 shows the results of two versions of
varSelRF. The best optimized gene selection procedures by
FiGS outperform the two different modes of varSelRF in
terms of the classification accuracy for all tested datasets.
Figure 4 Comparison of the best performing gene selection procedures identified by FiGS with other gene selection approaches in
terms of the classification accuracy. The names of the compared gene selection procedures are abbreviated as follows: ttest, t-test; Wilcoxon,
Wilcoxon rank sum test; and InfoGain, information gain method. 200 is the number of genes to select. varSelRF_SE0 and varSelRF_SE1 are two
versions of varSelRF each with the standard error (SE) term set to 0 and 1, respectively. FiGS_best is the best gene selection procedure identified
by FiGS; it produces the best classification accuracy with the smallest number of genes. The classification accuracy represented in the y-axis is 1-
.632+bootstrap error.
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on the basis of its internal optimization strategy, the classi-
fication performance seems to have been compromised.
During our comprehensive comparison of the various
gene selection procedures in FiGS for the six real micro-
array datasets, we found no single method is dominant
in its performance. Thus, a comprehensive search for
various gene selection procedures is both necessary and
useful. Although the gene selection methods included in
FiGS are not a complete spectrum of all available meth-
ods, the set of methods selected in FiGS seems reason-
able. Most methods in FiGS were selected almost
equally frequently in the final best gene selection proce-
dure for the different datasets. The best optimized gene
selection procedures selected by FiGS for the tested can-
cer microarray datasets outperformed other typical
approaches and recently developed methods.
Conclusion
Finding and using a proper gene selection procedure spe-
cific to a given microarray dataset is necessary and useful.
FiGS facilitates this procedure. It is an easy-to-use work-
bench that selects promising genes for disease classifica-
tion on the basis of a rigorous and comprehensive test of
various gene selection procedures for a given microarray
dataset. FiGS helps researchers efficiently and conveni-
ently determine biomarker candidates for clinical applica-
tion with a greater level of accuracy and reliability.
Availability and requirements
Project name: FiGS
Project homepage: http://gexp.kaist.ac.kr/figs
Operating system(s): Platform independent (web-
based application).
Programming language: R, Perl and Java script.
Other requirements: A web brower.
License: None for usage.
Any restrictions to use by non-academics: None.
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